Overview
Benqing Wu practices in Shenzhen, China. Wu is rated as an Advanced expert by MediFind in the treatment of Urea Cycle Disorders (UCD). Their top areas of expertise are Citrullinemia, Urea Cycle Disorders (UCD), Carnitine-Acylcarnitine Translocase Deficiency, and Intraventricular Hemorrhage of the Newborn.
Their clinical research consists of co-authoring 53 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 7 articles in the study of Urea Cycle Disorders (UCD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- CitrullinemiaWu isDistinguished. Learn about Citrullinemia.
- Advanced
- Carnitine-Acylcarnitine Translocase Deficiency
- Urea Cycle Disorders (UCD)
- Experienced
- Bronchopulmonary Dysplasia
- Carnitine Palmitoyltransferase 1 Deficiency
- Carnitine Palmitoyltransferase 2 Deficiency
- CholestasisWu isExperienced. Learn about Cholestasis.
- Congenital Hypothyroidism
- Glutaric Acidemia Type 1